106.40NOK+4.52%Mkt Cap: 9.23B NOKP/E: —Last update: 2026-05-13
Aker BioMarine ASA, a biotech innovator, develops and supplies krill-derived products for consumer health and wellness worldwide. The company operates through three segments: Human Health Ingredients (HHI), Consumer Heal…
Industry Peers
Packaged Foodsloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)25.86
PEG—
P/B7.10
P/S41.09
EV/EBITDA239.85
EV/Revenue41.86
EPS (TTM)-0.27
EPS (Forward)4.07
Cash Flow & Leverage
FCF Yield0.34%
FCF Margin13.95%
Operating CF4.20M NOK
CapEx (TTM)9.10M NOK
Net Debt/EBITDA4.49
Net Debt175.90M NOK
Technical
SMA 50104.80 (+1.5%)
SMA 20093.56 (+13.7%)
Beta0.27
S&P 52W Chg24.23%
Avg Vol (30d)13.92K
Avg Vol (10d)28.44K
Technical Indicators
RSI (14)58.6
MACD-0.2334
MACD Signal-0.7570
MACD Hist.+0.5236
BB Upper106.73 NOK
BB Middle102.08 NOK
BB Lower97.43 NOK
BB Width9.10%
ATR (14)3.716 NOK
Vol Ratio (20d)1.91x
52W Range
54.3082% of range118.00
52W High118.00 NOK
52W Low54.30 NOK
Profitability
Gross Margin44.84%
EBITDA Margin17.45%
Profit Margin-10.45%
Oper. Margin6.63%
ROE-15.83%
ROA-5.86%
Revenue Growth12.80%
Earnings Growth—
Balance Sheet
Debt/Equity1.26
Current Ratio3.32
Quick Ratio1.20
Book Value/Sh14.81 NOK
Cash/Share0.2260 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateSep 9, 2024
Pay Date—
Ownership
Shares Out.87.72M
Float9.05M
Insiders89.32%
Institutions5.68%
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)124.89 NOK
Target Range124.89 NOK – 124.89 NOK
# Analysts1
Company
Market Cap9.23B NOK
Enterprise Value9.40B NOK
Revenue (TTM)224.60M NOK
Gross Profit97.80M NOK
Net Income (TTM)-22.80M NOK
Revenue/Share2.561 NOK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees258
Last Price106.40 NOK
CountryNO
SectorConsumer Defensive
IndustryPackaged Foods
ISINNO0010886625